Now showing items 1-10 of 42
Elastic parity-violating electromagnetic current matrix element of the nucleon in a nonrelativistic quark model (vol A537, pg 551, 1992)
(Nuclear Physics A, 2001)
We show that the exact result based on closure, in Section 4.2 of Nucl. Phys. A 537 (1992) 551, that the contribution of all parity admixtures to the elastic parity-violating matrix element of the convection electromagnetic ...
Identification of residual stresses by instrumented elliptical indentation and inverse analysis (vol 41, pg 21, 2012)
(Mechanics Research Communications, 2012)
Intra and inter-laboratory variation in the scoring of micronucici and nucleoplasmic bridges in binucleated human lymphocytes - Results of an international slide-scoring exercise by the HUMN project (vol 534, pg 45, 2002)
(Mutation Research: Genetic Toxicology and Environmental Mutagenesis, 2003)
Determination of the integrated luminosity at HERA using elastic QED compton events (vol 72, 2163, 2012)
(European Physical Journal C. Particles and Fields, 2014)
Periodontitis and Cardiovascular Disease: Floss and Reduce a Potential Risk Factor for CVD (Retracted Article. See vol 62, pg 352, 2011)
There is evidence supporting an association between cardiovascular disease (CVD) and periodontitis. We determined whether patients with chronic periodontitis, who are otherwise healthy individuals, have higher serum ...
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) (vol 11, 33, 2016)
(World Journal of Emergency Surgery, 2017)
Measurement of D*(+/-) meson production and determination of F-2(c(c)over-bar) at low Q(2) in deep-inelastic scattering at HERA
(European Physical Journal C. Particles and Fields, 2012)
Three-quark exchange operators, crossing matrices and Fierz transformations in SU(2) and SU(3) (vol 42, pg 991, 2001)
(Journal of Mathematical Physics, 2004)
The Profile and Antimicrobial Activity of Bacillus Lipopeptide Extracts of Five Potential Biocontrol Strains (vol 8, pg 925, 2017)
(Frontiers in Microbiology, 2017)
Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O (vol 232, pg 507, 2017)
(Zeitschrift fur Kristallographie = New Crystal Structures, 2017)
C9H7BrN2O, monoclinic, C2/c (no. 15), a = 16.255(3) angstrom, b = 4.4119(9) angstrom, c = 25.923(5) angstrom, beta = 107.99(3)degrees, V = 1768.2(7) angstrom(3), Z = 8, R-gt(F) = 0.0450, wR(ref)(F-2) = 0.0960, T = 150 K.